ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results
Weight-loss drugs are the pharmaceutical industry’s equivalent of AI, in the sense of being a product with the capability to send shares soaring. Novo Nordisk A/S (NYSE: NVO), maker of Wegovy, saw its stock gap up more than 16% on August 8, after the
Announcement as on 09 August 2023

: Novo Nordisk says Wegovy reduced risk of adverse cardiovascular events by 20% in adults with obesity in trial
Novo Nordisk’s U.S.-listed stock NVODK:NOVO.B rose 10% premarket Tuesday, after the company said its obesity treatment semaglutide, marketed as Wegovy, met its main goal in a trial evaluating its ability to reduce cardiovascular events and not just help
Announcement as on 08 August 2023

Novo Nordisk weight-loss drug reduces cardiovascular events as well, study finds
Novo Nordisk weight-loss drug reduces cardiovascular events as well, study finds
Announcement as on 08 August 2023

Novo Nordisk to double India manufacturing, bring new drugs by 2025
Plans to bring new drugs by 2025 into the country, which is part of all its global clinical trials
Announcement as on 20 June 2023

: Novo Nordisk cracks down on alleged Ozempic imitations
Drug maker Novo Nordisk NVO on Tuesday sued five wellness spas and clinics in federal court, accusing them of unlawfully peddling what they said were modified copies of the popular drug Ozempic and other medications being used for weight loss, according to
Announcement as on 20 June 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 44.23
  • 12Day Average: 41.84
  • 20Day Average: 40.85
  • 50Day Average: 38.85
  • 100Day Average: 46.06
  • 150Day Average: 47.79
  • 200Day Average: 49.98

NVO Indicators & signals

Indicator MACD (12,26,9)

42.52, 41.05, 0.81
Indicator MACD is in positive zone

Indicator ADX (14)

44.33, 45.16, 17.42
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Wed May 2026 45.75 45.53 to 47.55 1.92% 1.41 times
05 Tue May 2026 44.89 44.21 to 45.12 1.13% 0.97 times
04 Mon May 2026 44.39 43.39 to 45.02 1.16% 0.82 times
01 Fri May 2026 43.88 43.10 to 44.04 3.93% 1.43 times
30 Thu Apr 2026 42.22 41.65 to 42.86 4.79% 1.37 times
29 Wed Apr 2026 40.29 39.70 to 40.78 -2.14% 0.88 times
28 Tue Apr 2026 41.17 41.10 to 42.08 -0.05% 0.89 times
27 Mon Apr 2026 41.19 40.55 to 41.73 0.05% 0.9 times
24 Fri Apr 2026 41.17 38.22 to 41.23 6.88% 1.12 times
23 Thu Apr 2026 38.52 38.02 to 39.20 -1.61% 0.67 times
22 Wed Apr 2026 39.15 38.85 to 39.33 -0.68% 0.95 times
21 Tue Apr 2026 39.42 38.70 to 40.20 -2.59% 1.37 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top